Bobby Gaspar - Net Worth and Insider Trading

Bobby Gaspar Net Worth

The estimated net worth of Bobby Gaspar is at least $614,827 dollars as of 2024-11-05. Bobby Gaspar is the CEO of Orchard Therapeutics PLC and owns about 36,816 shares of Orchard Therapeutics PLC (ORTX) stock worth over $614,827. Details can be seen in Bobby Gaspar's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bobby Gaspar has not made any transactions after 2022-04-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Bobby Gaspar

To

Bobby Gaspar Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bobby Gaspar owns 1 companies in total, including Orchard Therapeutics PLC (ORTX) .

Click here to see the complete history of Bobby Gaspar’s form 4 insider trades.

Insider Ownership Summary of Bobby Gaspar

Ticker Comapny Transaction Date Type of Owner
ORTX Orchard Therapeutics PLC 2022-04-01 director & See Remarks

Bobby Gaspar Latest Holdings Summary

Bobby Gaspar currently owns a total of 1 stock. Bobby Gaspar owns 36,816 shares of Orchard Therapeutics PLC (ORTX) as of April 1, 2022, with a value of $614,827.

Latest Holdings of Bobby Gaspar

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ORTX Orchard Therapeutics PLC 2022-04-01 36,816 16.70 614,827

Holding Weightings of Bobby Gaspar


Bobby Gaspar Form 4 Trading Tracker

According to the SEC Form 4 filings, Bobby Gaspar has made a total of 2 transactions in Orchard Therapeutics PLC (ORTX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Orchard Therapeutics PLC is the acquisition of 1,500 shares on April 1, 2022, which cost Bobby Gaspar around $11,100.

Insider Trading History of Bobby Gaspar

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bobby Gaspar Trading Performance

GuruFocus tracks the stock performance after each of Bobby Gaspar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bobby Gaspar is -25.97%. GuruFocus also compares Bobby Gaspar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bobby Gaspar within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bobby Gaspar's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bobby Gaspar

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -26.58 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -17.47 LIMIT LIMIT LIMIT LIMIT LIMIT

Bobby Gaspar Ownership Network

Ownership Network List of Bobby Gaspar

No Data

Ownership Network Relation of Bobby Gaspar

Insider Network Chart

Bobby Gaspar Owned Company Details

What does Orchard Therapeutics PLC do?

Who are the key executives at Orchard Therapeutics PLC?

Bobby Gaspar is the director & See Remarks of Orchard Therapeutics PLC. Other key executives at Orchard Therapeutics PLC include 10 percent owner & other: See Remark 1 Fmr Llc , 10 percent owner Ra Capital Healthcare Fund Lp , and 10 percent owner Ra Capital Management, L.p. .

Orchard Therapeutics PLC (ORTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Orchard Therapeutics PLC (ORTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orchard Therapeutics PLC (ORTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Orchard Therapeutics PLC (ORTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Orchard Therapeutics PLC Insider Transactions

No Available Data

Bobby Gaspar Mailing Address

Above is the net worth, insider trading, and ownership report for Bobby Gaspar. You might contact Bobby Gaspar via mailing address: Orchard Therapeutics Plc, 108 Cannon Street, London X0 Ec4n 6eu.